| Amitryptiline, imipramine, Desi-Ramin, nortriptyline | | NE, DA, 5HT receptor antagonist |
| Donepezil, rivastigmine and tacrine | | GABAergic signaling; atypical AD used as an antipsychotic. Does not lead to increased levels of neurotransmitters |
| Sumatriptan | | AED Ca2+ channel blocker used for bipolar disease |
| Eptinezumab/galcanezumab | | Monoamine Oxidase Inhibitor |
| Fluoxetine, trazodone, paroxetine, sertraline, cítalopram, escitalopram | | Serotonin antagonist that inhibits release of CGRP |
| Maprotiline + mirtrazapine | | 5HT + Norepinephrine re uptake inhibitor |
| Bupropion | | 5HT + NE re up take inhibitor |
| Duloxetine, amoxapine, venlafaxine | | Replaces Na+ in nerve cell and inhibits Ca2+ mediated release of NE/DA |
| Isocarboxazid, phenelzine, tranylcypromine | | AED Na+ channel blocker used for bipolar disease |
| St. John’s Wort | | Missing phrase2 - 16 |
| Lithium | | Atypical anti-psychotics; “weak antagonists at D1,2, 3, 5” + strong antagonist @ D4 |
| Carbamazepine | | Cholinesterase inhibitor (anticholinesterase) |
| Valproic Acid | | Monoclonal antibody that antagonizes CGRP |
| Clonazepam | | Rapid onset of psychomotor inhibition which may be life saving in case of violent or psychotic patient |
| Lamotrigine | | Tricyclic antidepressant |
| Lurasidone | | Norepinephrine re uptake inhibitor |
| Olanzapine | | Butyrophenone (DA receptor blockade) |
| Aripiprazole | | Norepinephrine + Dopamine + 5HT reuptake inhibitor |
| Zulpresso | | Selective serotonin reuptake inhibitor |
| Chlorpromazine, fluphenazine, thioridazine, trifluoperazine | | AED GABAergic used for bipolar disease |
| Haloperidol | | AED Na+ channel blocker used for bipolar disease |
| Clozapine, risperidone, olanzapine, quietapine, aripiprazole | | Phenothiazine anti-psychotic medications; block DA receptors |